Skip to main content
Medicine logoLink to Medicine
. 2016 Mar 3;95(8):e55f4. doi: 10.1097/01.md.0000481353.63355.f4

Prediction of Central Nervous System Relapse of Diffuse Large B-Cell Lymphoma Using Pretherapeutic [18F]2-Fluoro-2-Deoxyglucose (FDG) Positron Emission Tomography/Computed Tomography: Erratum

PMCID: PMC4779040  PMID: 31265689

In the article “Prediction of Central Nervous System Relapse of Diffuse Large B-Cell Lymphoma Using Pretherapeutic [18F]2-Fluoro-2-Deoxyglucose (FDG) Positron Emission Tomography/Computed Tomography”,1 which appeared in Volume 94, Issue 44 of Medicine, the specificity value of 99% should have read 77% in the “Risk Factors for Central Nervous System Relapse” section. The article has since been corrected online.

REFERENCE

  • 1.Song YS, Lee WW, Lee JS, et al. Prediction of central nervous system relapse of diffuse large B-cell lymphoma using pretherapeutic [18F]2-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography. Medicine. 2015. 94:e1978. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Medicine are provided here courtesy of Wolters Kluwer Health

RESOURCES